The effectiveness of cucurbitacin B in BRCA1 defective breast cancer cells.
about
Cucurbitacin E induces cell cycle G2/M phase arrest and apoptosis in triple negative breast cancerInhibition of Integrin-HER2 signaling by Cucurbitacin B leads to in vitro and in vivo breast tumor growth suppressionVASP activation via the Gα13/RhoA/PKA pathway mediates cucurbitacin-B-induced actin aggregation and cofilin-actin rod formationGrowth inhibitory effect of Cucurbitacin E on breast cancer cells.Cucurbitacins: A Systematic Review of the Phytochemistry and Anticancer Activity.Cucurbitacin B inhibits immunomodulatory function and the inflammatory response in macrophages.
P2860
The effectiveness of cucurbitacin B in BRCA1 defective breast cancer cells.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The effectiveness of cucurbitacin B in BRCA1 defective breast cancer cells.
@ast
The effectiveness of cucurbitacin B in BRCA1 defective breast cancer cells.
@en
The effectiveness of cucurbitacin B in BRCA1 defective breast cancer cells.
@nl
type
label
The effectiveness of cucurbitacin B in BRCA1 defective breast cancer cells.
@ast
The effectiveness of cucurbitacin B in BRCA1 defective breast cancer cells.
@en
The effectiveness of cucurbitacin B in BRCA1 defective breast cancer cells.
@nl
prefLabel
The effectiveness of cucurbitacin B in BRCA1 defective breast cancer cells.
@ast
The effectiveness of cucurbitacin B in BRCA1 defective breast cancer cells.
@en
The effectiveness of cucurbitacin B in BRCA1 defective breast cancer cells.
@nl
P2093
P2860
P1433
P1476
The effectiveness of cucurbitacin B in BRCA1 defective breast cancer cells
@en
P2093
Moltira Promkan
Pimpicha Patmasiriwat
Subhas Chakrabarty
Sumana Dakeng
P2860
P304
P356
10.1371/JOURNAL.PONE.0055732
P407
P577
2013-02-05T00:00:00Z